pharmacopsychiatry
130595
EN
DE
Home
Produkte
Zeitschriften
Bücher
Buchreihen
Service
Service für Bibliotheken
Hilfe
Kontakt
Portal
Pharmacopsychiatry
Volltextsuche
Volltextsuche
Autorensuche
Titelsuche
DOI-Suche
Metadatensuche
Zeitschrift
Über diese Zeitschrift
Herausgeber
Informationen zur DFG-Nationallizenz
Impressum
X
Autor*innen
Autorenhinweise
Manuskript einreichen
Abonnement
Ihr Abonnement: Kontakt & Information
Lizenzen: Kontaktpartner Institutionen
AGNP
Offizielles Organ der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Collections
Pharmacopsychiatry Women
About Women in Medicine
Open Access
nicht eingeloggt
Login
Benutzername oder E-Mail-Adresse:
Passwort:
Zugangsdaten vergessen?
Neu registrieren
OpenAthens/Shibboleth Login
Warenkorb
Jahre (Archiv)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
Ausgaben
Aktuelle Ausgabe
Kostenlose Probeausgabe (01/2024)
Ähnliche Zeitschriften
Drug Research
Planta Medica
PiD - Psychotherapie im Dialog
Bücher zum Thema
Psychiatrie, Psychotherapie, Psychosomatik
Abstracts (HTML)
Autorenliste
A
B
C
D
E
F
G
H
I
K
L
M
N
P
R
S
T
U
V
W
Z
Hart, M X
Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors
Hart, X. M.
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range
Hart, X.M.
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
How valid are therapeutic reference ranges for psychotropic drugs?
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination
Havemann-Reinecke, U.
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
Drug interactions in patients undergoing opioid maintenance therapy
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range
Hefner, G.
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range
Hellenschmidt, T.
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting
Hermans, R.A.
Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents
Heuschmann, P.
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting
Hiemke, C
Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors
Drug interactions in patients undergoing opioid maintenance therapy
Hiemke, C.
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
How valid are therapeutic reference ranges for psychotropic drugs?
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range
Hillegers, M.H.J.
Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents
Hirjak, D.
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination